Literature DB >> 1170284

Hereditary myokymia and periodic ataxia.

D H VanDyke, R C Griggs, M J Murphy, M N Goldstein.   

Abstract

A kindred in which at least 11 individuals in 3 consecutive generations have continuous muscle movement, i.e., myokymia, and periodic ataxia, has been studied. Three patients, a 24-year-old woman, her 4-year-old son and her 27-year-old sister, have been studied in detail. The disorder is inherited as an autosomal-dominant trait and presents in early childhood with attacks of ataxia of 1-2 min in duration, with associated jerking movements of the head, arms and legs. Attacks are provoked by abrupt postural change, emotional stimulus, and caloric-vestibular stimulation. At the age of 12 years approximately, facial and extremity myokymia appears. Physical findings include large calves, normal muscle strength and widespread myokymia of face, hands, arms and legs with a hand posture resembling carpopedal spasm. EMG studies at rest showed continuous spontaneous activity of otherwise normal motor units. Nerve conduction velocities were normal. Gastrocnemius biopsy in 2 patients showed fiber type grouping and small angular fibers, and was consistent with denervation. Histographic analysis of the biopsies demonstrated enlargement of both fiber types, particularly of Type I fibers. These findings are consistent with chronic denervation and an abnormality of motor neuron population or firing. The myokymia described here is of interest not only because of its genetic association with a movement disorder, but also because the muscle findings support a peripheral basis for the muscle movements.

Entities:  

Mesh:

Year:  1975        PMID: 1170284     DOI: 10.1016/0022-510x(75)90191-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  31 in total

Review 1.  Ion channel genes and human neurological disease: recent progress, prospects, and challenges.

Authors:  E C Cooper; L Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 gene.

Authors:  A Poujois; J-Ch Antoine; A Combes; R L Touraine
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

3.  Familial dystonic choreoathetosis with myokymia; a sleep responsive disorder.

Authors:  E Byrne; O White; M Cook
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

Review 4.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

5.  Kinesigenic Triggers in Episodic Ataxia Type 1.

Authors:  Claudio M de Gusmao; Lucas Rogerio Garcia; Aaron Jesuthasan; Meaghan Muir; Alex Paciorkowski; Jonathan W Mink; Laura Silveira-Moriyama
Journal:  Mov Disord Clin Pract       Date:  2020-07-19

6.  A Novel Frameshift CACNA1A Mutation Causing Episodic Ataxia Type 2.

Authors:  Alexander Balck; Sinem Tunc; Johanna Schmitz; Ronja Hollstein; Frank J Kaiser; Norbert Brüggemann
Journal:  Cerebellum       Date:  2018-08       Impact factor: 3.847

7.  Mechanism of accelerated current decay caused by an episodic ataxia type-1-associated mutant in a potassium channel pore.

Authors:  Christian J Peters; Daniel Werry; Hira S Gill; Eric A Accili; David Fedida
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

8.  A gene for episodic ataxia/myokymia maps to chromosome 12p13.

Authors:  M Litt; P Kramer; D Browne; S Gancher; E R Brunt; D Root; T Phromchotikul; C J Dubay; J Nutt
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

9.  The syndrome of continuous muscle fibre activity following gold therapy.

Authors:  W Grisold; B Mamoli
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

Review 10.  Potassium Channels in Epilepsy.

Authors:  Rüdiger Köhling; Jakob Wolfart
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.